Antioxidant LY231617 enhances electrophysiologic recovery after global cerebral ischemia in dogs
Authors:
- Thomas J. K. ToungTTThomas J. K. Toung
- Anish BhardwajABAnish Bhardwaj
- Mimi WangMWMimi Wang
- Jeffrey R. KirschJKJeffrey R. Kirsch
- Richard J. TraystmanRTRichard J. Traystman
- 1 January 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 28 (1) , 196-201
Abstract
The potent antioxidant LY231617 (2,6-bis(1,1-dimethylethyl)-4-[[(1-ethyl)amino]methyl]phenol hydrochloride) is cytoprotective in models of focal and global cerebral ischemia. We tested the hypothesis that administration of LY231617, before the insult, would improve recovery of cerebral electrical activity and metabolic function after transient global cerebral ischemia by improving cerebral blood flow (CBF) during the reperfusion period. Randomized, controlled, prospective study. Research laboratory at a university teaching hospital. Twenty-four male beagle dogs. All experiments were performed under pentobarbital anesthesia and controlled conditions of normoxia, normocarbia, and normothermia. Twelve control dogs received 20 mL/kg saline (vehicle) bolus into the right atrium and 0.01 mL/kg/min iv, beginning 20 mins before 13 mins of global cerebral ischemia (by aortic occlusion). The dogs in the drug-treated group received LY231617 as a 10-mg/kg bolus 20 mins before ischemia and 5 mg/kg/hr throughout reperfusion (n = 12). CBF was measured using radiolabeled microspheres. Total CBF, cerebral oxygen consumption, and somatosensory evoked potentials (SEP) were measured during 240 mins of reperfusion. CBF was similar in both vehicle- and LY231617-treated animals at baseline and throughout the experimental period. In all animals, SEP became isoelectric between 60 and 100 secs after cross-clamping of the ascending aorta. SEP amplitude recovery was significantly higher in drug-treated animals compared with controls (73% ± 15% vs. 39% ± 14% [mean ± SEM] from baseline at 120 mins [ p < .05] and 86% ± 12% vs. 49% ± 14% from baseline at 240 mins [ p < .05]). LY231617 improves recovery of cerebral electrical function after complete transient global ischemia via mechanisms unrelated to cerebral circulatory effects.Keywords
This publication has 32 references indexed in Scilit:
- The antioxidant LY231617 reduces global ischemic neuronal injury in rats.Stroke, 1993
- Recombinant human superoxide dismutase can attenuate ischemic neuronal damage in gerbilsLife Sciences, 1992
- Oxygen radical mechanisms of brain injury following ischemia and reperfusionJournal of Applied Physiology, 1991
- LY178002 reduces rat brain damage after transient global forebrain ischemia.Stroke, 1991
- Excitatory amino acid neurotoxicity and neurodegenerative diseaseTrends in Pharmacological Sciences, 1990
- Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.Proceedings of the National Academy of Sciences of the United States of America, 1990
- Excitatory amino acids and neuropsychiatrie disordersBiological Psychiatry, 1989
- Generation of hydrogen peroxide by brain mitochondria: The effect of reoxygenation following postdecapitative ischemiaArchives of Biochemistry and Biophysics, 1989
- Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F.Stroke, 1988
- Glutamate and the pathophysiology of hypoxic–ischemic brain damageAnnals of Neurology, 1986